ORIC Pharmaceuticals Inc.
10.43
0.52 (5.25%)
At close: Jan 15, 2025, 11:49 AM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -4.7 -2.55 -7.18 -7.64 -30.24 -23.09 -34.98
PS Ratio n/a n/a n/a n/a n/a n/a n/a
PB Ratio 2.11 1.05 2.04 2.56 8.76 -7.66 29.95
P/FCF Ratio -5.47 -3.02 -9.22 -16.17 -31.71 -23.26 -36.15
P/OCF Ratio -5.52 -3.11 -9.37 -16.41 -32.75 -23.85 -36.99
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.05 0.01 0.01 n/a n/a n/a n/a
Quick Ratio 10.39 13.68 15.87 32.96 16.81 16.84 10.20
Current Ratio 10.39 13.68 15.87 32.96 16.81 16.84 10.20
Asset Turnover n/a n/a n/a n/a n/a n/a n/a
Interest Coverage n/a -34.69 n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.45 -0.41 -0.28 -0.34 -0.29 0.33 -0.86
Return on Assets (ROA) -0.4 -0.37 -0.26 -0.33 -0.27 -0.46 -0.73
Return on Capital (ROIC) -0.48 -0.4 -0.28 -0.26 -0.32 -0.51 -0.82
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a